Stay updated on Cardiol Therapeutics Press Releases

Sign up to get notified when there's something new on the Cardiol Therapeutics Press Releases page.
Latest website image capture
Clouds background image

Latest updates to the Cardiol Therapeutics Press Releases page

  1. Check
    6 days ago
    Change Detected
    Summary
    Cardiol Therapeutics’ displayed share prices changed from $1.23 to $1.10 on NASDAQ and from $1.78 to $1.58 on the TSX.
    Difference
    0.4%
    Check dated 2026-10-18T22:22:32.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    Cardiol Therapeutics’ displayed share prices changed to $1.23 for NASDAQ:CRDL and $1.78 for TSX:CRDL.
    Difference
    0.4%
    Check dated 2026-10-11T22:29:53.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    Cardiol Therapeutics’ displayed share prices changed from $1.71 to $1.41 on NASDAQ and from $2.43 to $2.03 on the TSX.
    Difference
    0.4%
    Check dated 2026-10-04T21:59:20.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    Stock prices were updated to $1.71 and $2.43. A new September 23, 2026 MAVERIC enrollment press release was added to the Press Releases list, while the May 14, 2026 conference item and its related content were removed.
    Difference
    1%
    Check dated 2026-09-27T22:25:49.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    Added new stock price values ($1.875, $2.61), the September 16, 2026 date, and a new press release title Cardiol Therapeutics Announces Warrant Exercise for Over USD $7 Million in Proceeds to the Press Releases page. Removed older stock prices ($1.995, $2.75), the May 7, 2026 date, and Cardiol Therapeutics’ Phase II MAvERIC Results Accepted for Publication in the Journal of the American Heart Association.
    Difference
    1%
    Check dated 2026-09-20T20:21:29.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    The Press Releases page now shows updated stock quotes in the header ($1.995 and $2.75), and adds entries for the US$150 million shelf prospectus filing and two upcoming investor conferences on Sept 9–10, 2026. It also removes several MAVERIC-related press releases from April 2026.
    Difference
    4%
    Check dated 2026-09-13T18:05:42.000Z thumbnail image

Stay in the know with updates to Cardiol Therapeutics Press Releases

Enter your email address, and we'll notify you when there's something new on the Cardiol Therapeutics Press Releases page.